Important Notes These are the points most often dropped when AHK-Cu is marketed as an injectable hair-growth peptide. No human trial exists state it plainly: there is no clinical trial of AHK-Cu by any route, and the entire peptide-specific peer-reviewed base is one 2007 study that was ex vivo and in vitro [1]
Reported or proposed issue Stinging or irritation after injection Evidence source Informal route-specific reports Known or theoretical
A lot-specific Certificate of Analysis (COA) is available to document identity, purity, and measured content
Peri-Meno hates me! Apr 1, 2026 I don't need to lose weight
Studies confirm 50% drops by midlife, linking to aging symptoms.[1][9] Restoring NAD+ has been shown in animal studies to improve lifespan and healthspan, with human trials indicating benefits in muscle function and cognitive performance
Some users report feeling intoxicated more quickly than before starting therapy